North America


Some Laid Off Employees Called Back At US FDA

 

Some FDA employees who were recently laid off by the Trump Administration are being called back to work, multiple sources confirmed to the Pink Sheet.

Bayer Consumer Health Expands North America And LATAM Supply Capacity

Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.

US Proposal To Remove Phenylephrine From OTC Monograph Could Stress-Test Streamlined Process

 

Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.

FDA Clears Qnovia’s NRT Inhalation IND, Commits To ‘Stimulating’ Smoking Cessation Innovation

 

Qnovia notes NRT inhalation product recently received investigational new drug clearance from FDA as agency and NIH say innovation needed smoking cessation to help improve rate of success for quitting the habit that kills around 500,000 US consumers annually.

Latin America


Bayer Consumer Health Expands North America And LATAM Supply Capacity

Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.

Perrigo Q2 Results Down Nearly 11% On Formula Slump Despite Women’s Health Sales Jump On Opill

 

OTC private label/store brand product giant’s Q2 net sales down 10.7% to $1.1bn, but women’s health product sales jump 31.4% largely on Opill launched late in Q1. Biggest hit to results from infant formula business, down a reported 82% due to ongoing manufacturing quality-control remediation.

Opill Launch Delivers For Perrigo While Growing Pains Slow Overall First-Quarter Results

 

Perrigo spares little about Opill’s launch, advertising and outlook in Q1 earnings briefing, but management also makes clear it’s a large firm and some other segments of its global consumer health products business are holding back overall results.

Herbalife's Rising Digital Platform Floats All Boats Other Than Marketing To GLP-1 Patients

 

Direct seller reports Q1 sales up 1% to $1.3bn but net sales off 17.1% from year-ago period to $24.3m. Its distributor ranks jumped so far in 2024, particularly in China, where changes were made in the past year including new company leadership.

Europe


EU Deforestation Law: Parliament Votes For Delay For All Manufacturers Until End Of 2026

 
• By 

While no doubt welcome, yet another delay to the EU Deforestation Law and suggestion for another review next year could mean a “never-ending” regulatory exercise that creates uncertainty for manufacturers selling products containing or having been made using materials like palm oil, soya and wood.

PAGB Wants 25 Rx-To-OTC Switches Over Next Five Years In The UK

 
• By 

UK consumer healthcare industry association, PAGB, suggests improvements that could help accelerate Rx-to-OTC switch in the country.

‘Fake News’ And Chatbots Pose Threat To Italy’s Responsible Self-Medication Model

 
• By 

A new cohort of “techno-enthusiasts” who are highly susceptible to misinformation and inappropriate self-care decisions are undermining Italy's responsible self-medication model, finds a report by Italian self-care industry association, Assosalute, and independent researcher Censis.

Over The Counter Special: Enabling Digital Self-Care, With PAGB’s Michelle Riddalls

 
• By 

In the second part of a special Self-Care Week episode of Over the Counter, HBW Insight speaks to PAGB CEO Michelle Riddalls about what the association is doing to promote self-care.

Asia


Opella: Unlock Volume Growth By Expanding Access And Deepening Category Penetration

 
• By 

Negative growth in global OTC market sales volume means that “as an industry, we're not doing good enough,” argues Opella’s Asia Pacific, Middle East and Africa (AMEA) head, Carol-Ann Stewart, in this exclusive feature interview.

How Opella Is Leveraging Independence To Unleash China Growth

 
• By 

HBW Insight speaks to Opella's Asia Pacific, Middle East and Africa (AMEA) head, Carol-Anne Stewart, about the company's China growth strategy in this exclusive interview.

Japan Switches Rohto’s Algard Epinastine Eye Drops, Approves OTC Black Cohosh For Menopause

 
• By 

Japan’s Ministry of Health, Labor and Welfare continues to widen access to non-prescription medicines with another Rx-to-OTC switch – Rohto Algard Epinastine Eye Drops – and a direct OTC approval of Sato Pharmaceutical's Menofeminin (black cohosh) menopause treatment.

Vietnam Cuts Red Tape Accelerating Product Launches And Simplifying Compliance

 
• By 

Thanks to a bureaucracy cutting drive by the Vietnamese government, health businesses operating in the country will benefit from a reduced regulatory burden, accelerated product launches, and lower compliance costs.

International


The Global Allergy Market In 2025: ‘Growth Is Back, But Not Like Before’

 
• By 

The global allergy market is “expanding again but on new terms, driven by a mix of regional strength, evolving consumer behaviors, and an increasingly diverse competitive field,” according to the latest IQVIA Consumer Health analysis.

GSCF: Self-Care Key To UN’s Noncommunicable Disease Aims

 
• By 

The United for Self-Care Coalition publishes a manifesto that it hopes will accelerate the UN’s vision set out in a recent political declaration that aims to prevent and control non-communicable diseases and promote mental health and wellbeing.

Deloitte: HCPs Driving Consumer Health Purchasing Decisions And Brand Switching

 
• By 

A recent Deloitte survey found that women are emerging as the “chief health officers” of everyday life, younger consumers are something of an enigma, being both adventurous and skeptical, and attitudes to health technologies vary geographically.

Over The Counter: How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten

 
• By 

HBW Insight catches up with PA Consulting's personalization and consumer expert Rhea Patten to find out what “vibes” are and how understanding this aspect of “consumer centricity” better can help consumer health companies grow their brands.